Company: PSTV
Filing Date: 2025-05-23
Form Type: 8-K
Source: 0001193125-25-125860
Chunk: 1

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-05-23
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01      Regulation FD Disclosure.  

On May 23, 2025, the Company issued a press release in accordance with Nasdaq Listing Rule 5810(b) announcing that the Company had received the Notice. A copy of the press release is attached hereto as Exhibit 99.1.

The information set forth in this Item 7.01 and Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of such section. The information in this Item 7.01 and Exhibit 99.1 attached hereto, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing to this Current Report on Form8-K.